|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170.00 THB | +1.19% |
|
+1.49% | +7.94% |
| Capitalization | 135B 4.29B 3.63B 3.33B 3.15B 5.85B 389B 6.11B 38.7B 15.3B 187B 16.1B 15.77B 683B | P/E ratio 2025 * |
18.8x | P/E ratio 2026 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 121B 3.84B 3.25B 2.98B 2.82B 5.24B 348B 5.47B 34.63B 13.7B 167B 14.41B 14.12B 611B | EV / Sales 2025 * |
4.74x | EV / Sales 2026 * | 4.47x |
| Free-Float |
85.99% | Yield 2025 * |
2.95% | Yield 2026 * | 3.1% |
Last Transcript: Bumrungrad Hospital
| 1 day | +1.19% | ||
| 1 week | +1.49% | ||
| Current month | +1.49% | ||
| 1 month | +9.68% | ||
| 3 months | -3.13% | ||
| 6 months | -10.29% | ||
| Current year | +7.94% |
| 1 week | 163.5 |  | 174 |
| 1 month | 136 | | 174 |
| Current year | 136 | | 174 |
| 1 year | 130 | | 198.5 |
| 3 years | 130 | | 284 |
| 5 years | 116.5 | | 284 |
| 10 years | 90.5 | | 284 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2019-01-30 | |
Oraphan Buamuang
DFI | Director of Finance/CFO | 52 | 2019-08-18 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 1993-09-07 | |
Chong Toh
BRD | Director/Board Member | 57 | 2001-04-07 |
| Director/Board Member | 65 | 2001-04-07 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | +1.49% | -4.49% | -20.56% | 4.29B | |
| -2.35% | +2.75% | +55.78% | +96.56% | 114B | |
| +2.65% | +5.14% | +45.07% | -8.87% | 99.46B | |
| +1.06% | +5.40% | +33.84% | +81.61% | 33.11B | |
| +0.47% | -2.06% | -13.68% | +12.37% | 23.8B | |
| -0.37% | +2.09% | +12.56% | +12.12% | 22.98B | |
| -0.83% | +1.97% | +17.26% | +30.69% | 21.22B | |
| +2.76% | +6.39% | +43.35% | +269.22% | 17.7B | |
| -0.19% | -2.03% | +47.53% | +44.50% | 17.56B | |
| +0.97% | +8.60% | +16.30% | +51.24% | 13.66B | |
| Average | +0.54% | +3.10% | +25.35% | +56.89% | 36.82B | |
| Weighted average by Cap. | +0.21% | +3.38% | +38.35% | +55.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 25.54B 812M 686M 629M 595M 1.11B 73.49B 1.15B 7.31B 2.89B 35.31B 3.04B 2.98B 129B | 26.88B 854M 722M 662M 627M 1.16B 77.34B 1.21B 7.7B 3.04B 37.16B 3.2B 3.14B 136B |
| Net income | 7.55B 240M 203M 186M 176M 327M 21.73B 341M 2.16B 855M 10.44B 900M 881M 38.15B | 7.94B 252M 213M 195M 185M 344M 22.84B 359M 2.27B 899M 10.97B 946M 926M 40.11B |
| Net Debt | -14.19B -451M -381M -349M -331M -615M -40.83B -641M -4.06B -1.61B -19.62B -1.69B -1.66B -71.7B | -14.9B -473M -400M -367M -347M -645M -42.87B -673M -4.27B -1.69B -20.6B -1.78B -1.74B -75.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-06 | 170.00 ฿ | +1.19% | 5,555,264 |
| 26-02-05 | 168.00 ฿ | +1.82% | 3,158,540 |
| 26-02-04 | 165.00 ฿ | -0.30% | 2,110,016 |
| 26-02-03 | 165.50 ฿ | +0.30% | 2,275,208 |
| 26-02-02 | 165.00 ฿ | -1.49% | 3,150,726 |
End-of-day quote Thailand S.E., February 05, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BH Stock
Select your edition
All financial news and data tailored to specific country editions
